Giris ve amaç: Bu çalismanin amaci kronik hepatit B ve C’de cinsel yolla bulasimin arastirilmasidir. Gereç ve yöntem: Çalismamiza kronik hepatit B ve hepatit C nedeniyle takip edilen hastalar ve esleri alindi. Eslerde HBsAg ve anti-HCV bakildi. Bulgular: Kronik hepatit B hastalari nin eslerinde HBsAg prevalansi %14.4 bulundu. HBsAg (+) ve HBsAg (-) esler arasinda; yas, cinsiyet, evlilik süresi, transfüzyon ve cerrahi girisim öyküsü yönünden anlamli farklilik bulunmadi. Kronik hepatit C hastalarinin eslerinde anti-HCV seroprevalansi %5.5 bulundu. Anti- HCV (+) ve anti-HCV (-) esler arasinda; yas, cinsiyet, evlilik süresi, transfüzyon ve cerrahi girisim öyküsü yönünden anlamli farklilik bulunmadi. Kronik hepatit B ve C partner gruplari arasinda; yas, cinsiyet, evlilik süresi ve seroprevalans yönünden anlamli farklilik saptanirken, transfüzyon ve cerrahi girisim öyküsü yönünden anlamli farklilik saptanmadi. Sonuç: Bu bulgular kronik hepatit B’li hastalardan partnerlerine cinsel yolla bulastiricilik riskinin yüksek oldugunu, eslerinin mutlaka bagi siklanmasi ve güvenli cinsel pratikler önerilmesi gerektigini, aksine kronik hepatit C’li hastalardan partnerlerine cinsel yolla bulastiricilik riskinin düsük oldugunu ve multipl cinsel partneri olanlar disinda cinsel pratiklerinde bir degisiklik gerekmeyebilecegini düsündürmektedir.
Background and aims: This study was designed to evaluate the characteristics of sexual transmission of chronic hepatitis B and C in spouses of patients with chronic hepatitis B and C. Materials and methods: This study included patients with chronic hepatitis B and C, and their spouses. HBsAg and anti-HCV tests were carried out in spouses. Results: The prevalence of HBsAg in spouses of patients with chronic hepatitis B was 14.4%. There were no significant differences between HBsAg (+) and HBsAg (-) spouses with regard to mean age, gender, duration of marriage, previous transfusion, and history of surgical intervention. The prevalence of anti-HCV in spouses of patients with chronic hepatitis C was 5.5%. There were no significant differences between anti-HCV (+) and anti-HCV (-) spouses with regard to mean age, gender, duration of marriage, previous transfusion, and history of surgical interventions. Significant differences between partner groups with chronic hepatitis B and C with respect to age, gender, duration of marriage and seroprevalence rates were noted, while there were no differences in terms of previous transfusions or history of surgical interventions. Conclusion: Our findings suggest that there is a high risk of sexual transmission for spouses of patients with chronic hepatitis B, necessitating safe sexual practices and immunization. The risk of transmission for spouses of patients with chronic hepatitis C appears to be low and thus, unless the patient has multiple sexual partners, a change in sexual practices is deemed unnecessary.